Manhattan Street Capital, best known for its Reg A+ securities offerings, is pitching shares in Impossible Foods, a competitor to Beyond Meat (NASDAQ:BYND). As you probably know, Beyond Meat went public in mid-2019 raising about $240 million on a valuation of $1.5 billion. Shares were… Read More
Manhattan Street Capital has circulated an email that outlines the cost of doing a Reg A+ securities offering. While I know not everyone may agree with their analysis, Manhattan Street Capital is a platform that facilitates Reg A+ offerings and thus has some boots on… Read More
InSitu Biologics is reporting that it has topped $2 million using the Reg A+ crowdfunding exemption. The company anticipates reaching $10 million in equity capital as the campaign continues into 2019. InSitu Biologics is a biotech firm that claims positive initial results in pre-clinical studies… Read More
Manhattan Street Capital (MSC) has launched “ManhattanStreet-ICO”program for crowdfunding companies. The platform also said it will now accept cryptocurrency for issuers using Reg A+ and Reg D offerings. Several other investment crowdfunding platforms have recently announced their intent to facilitate ICOs. The shift by Manhattan… Read More
Manhattan Street Capital has entered the Reg A+ crowdfunding space with its first offer for Blue Marble Biomaterials. The platforms is accepting investor indications of interest now. Manhattan Street Capital has positioned its platform as a Reg A+ specialist. This updated securities exemption was created… Read More
Crowdfund Insider is the leading news website covering the emerging global industry of disruptive finance including investment crowdfunding, Blockchain, online lending, and other forms of Fintech.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it and agree to our terms of service.Ok